University of Pittsburgh student startup HiberSense has been selected as one of 35 companies from across the nation to participate in the first University Startups Demo Day at Congress on Sept. 20 in Washington, D.C. Read more
Kurt Rote, left, CEO of Western Oncolytics and Dr. Stephen Thorne, chief scientific officer, in Dr. Thorne's research lab at the Hillman Cancer Center.
August 15, 2016 The University of Pittsburgh Innovation Institute reported that Pitt Innovators were issued five U.S. patents in July 2016.
The University of Pittsburgh has licensed technology for a microneedle patch to deliver drug to treat and immunize skin cancer patients. SkinJect, Inc., is a Pittsburgh-based company formed around technology developed by Louis Falo, M.D., who chair's Pitt's Department of Dermatology, and O.Burak Ozdoganlar, Ph.D., Professor of Mechanical Engineering at Carnegie Mellon University. Read more